Recurrent respiratory papillomatosis

Pediatric ENT

Volumn , Issue , 2007, Pages 255-265

  Wiatrak, Brian J ^a  

^a CHILDREN S HOSPITAL OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956015517     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-33039-4_29     Document Type: Chapter

References (50)

1. Aaltonen LM, Rihkanen H, Vaheri A (2002) Human papillomavirus in the larynx. Laryngoscope 112:700-707.
2. Abramson AL, DiLorenzo TP, Steinberg BM (1990) Is papillomavirus detectable in the plume of laser-treated laryngeal papilloma? Arch Otolaryngol Head Neck Surg 116:604-607.
3. Armstrong LR, Derkay CS, Reeves WC (1999) Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force. Arch Otolaryngol Head Neck Surg 125:3-8.
4. Bower CM, Waner M, Flock S, et al (1998) Flash pump dye laser treatment of laryngeal papillomas. Ann Otol Rhinol Laryngol 107:1001-1005.
5. Boyle WF, Riggs JL, Oshiro LS, et al (1973) Electron microscopic identification of papova virus in laryngeal papilloma. Laryngoscope 83:1102-1108.
6. Brown L, Wiatrak B (2002) Concurrent respiratory and cutaneous papillomatosis with human papillomavirus type 11. Otolaryngol Head Neck Surg 127:465-466.
7. Buchinsky FJ, Derkay CS, Leal SM, et al (2004) Multicenter initiative seeking critical genes in respiratory papillomatosis. Laryngoscope 114:349-357.
8. Cole RR, Myer CM III, Cotton RT (1989) Tracheotomy in children with recurrent respiratory papillomatosis. Head Neck 11:226-230.
9. Derkay CS (1995) Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg 121:1386-1391.
10. Derkay CS (2001) Recurrent respiratory papillomatosis. Laryngoscope 111:57-69.
11. Derkay CS, Darrow DH (2006) Recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 115:1-11.
12. Derkay CS, Malis DJ, Zalzal G, et al (1998) A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. Laryngoscope 108:935-937.
13. Derkay CS, Smith RJ, McCay J, et al (2005) HspE7 treatment of pediatric recurrent respiratory papillomatosis: final results of an open-label trial. Ann Otol Rhinol Laryngol 114:730-737.
14. Gabbott M, Cossart YE, Kan A, et al (1997) Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol 35:3098-3103.
15. Green H (1846) A treatise on diseases of the air passages: comprising an inquiry into the history, pathology, causes and treatment of those affections of the throat called bronchitis, chronic laryngitis, clergyman's sore throat. Wiley and Putnam, New York.
16. Hajek EF (1956) Contribution to the aetiology of laryngeal papilloma in children. J Laryngol Otol 70:166-168.
17. Haleden C, Majmudar B (1986) The relationship between juvenile laryngeal papillomatosis and maternal condylomata acuminate. J Reprod Med 318:804-807.
18. Helmrich G, Stubbs TM, Stoerker J (1992) Fatal maternal laryngeal papillomatosis in pregnancy: a case report [corrected][erratum appears in Am J Obstet Gynecol 166:1313].
19. Helmrich G, Stubbs TM, Stoerker J (1992) Fatal maternal laryngeal papillomatosis in pregnancy: a case report [corrected], Am J Obstet Gynecol 166:524-525.
20. Inglis AF Jr (2005) Cidofovir and the black box warning [Comment. Editorial]. Ann Otol Rhinol Laryngol 114:834-835.
21. Jackson C (1922) Benign growths in the larynx. In: Jackson C (ed) Bronchoscopy and Esophagoscopy. A Manual of Peroral Endoscopy and Laryngeal Surgery. WB Saunders, Philadelphia, PA, pp 203-208.
22. Kashima HK and the Papilloma Study Group (1985) Scoring system to assess severity and course in recurrent respiratory papillomatosis. In: Howley PM Broker T (ed) Papillomaviruses: Molecular and Clinical Aspects. Alan R. Liss, New York, pp 125-135.
23. Kashima H, Mounts P, Leventhal B, et al (1993) Sites of predilection in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 102:580-583.
24. Kosko JR, Derkay CS (1996) Role of cesarean section in prevention of recurrent respiratory papillomatosis-is there one? Int J Pediatr Otorhinolaryngol 35:31-38.
25. Lindman JP, Lewis LS, Accortt N, et al (2005) Use of the Pediatric Quality of Life Inventory to assess the health-related quality of life in children with recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 114:499-503.
26. Mackenzie M (1880) Non-malignant tumors of the larynx. diseases of the pharynx, larynx, and trachea. William Wood, New York, pp 218-243.
27. McMillan K, Shapshay SM, McGilligan JA, et al (1998) A 585-nanometer pulsed dye laser treatment of laryngeal papillomas: preliminary report. Laryngoscope 108:968-972.
28. Myer CM III, Willging JP, McMurray S, et al (1999) Use of a laryngeal micro resector system. Laryngoscope 109:1165-1166.
29. Padayachee A, Prescott CA (1993) Relationship between the clinical course and HPV typing of recurrent laryngeal papillomatosis. The Red Cross War Memorial Children's Hospital experience 1982-1988. Int J Pediatr Otorhinolaryngol 26:141-147.
30. Pasquale K, Wiatrak B, Woolley A, et al (2003) Microdebrider versus CO2 laser removal of recurrent respiratory papillomas: a prospective analysis. Laryngoscope 113:139-143.
31. Pignatari S, Smith EM, Gray SD, et al (1992) Detection of human papillomavirus infection in diseased and nondiseased sites of the respiratory tract in recurrent respiratory papillomatosis patients by DNA hybridization. Ann Otol Rhinol Laryngol 101:408-412.
32. Poland GA, Jacobson RM, Koutsky LA, et al (2005) Immunogenicity and reactogenicity of a novel vaccine for human papillomavirus 16: a 2-year randomized controlled clinical trial. Mayo Clin Proc 80:601-610.
33. Pransky SM, Brewster DF, Magit AE, et al (2000) Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 126:1239-1243.
34. Rabah R, Lancaster WD, Thomas R, et al (2001) Human papillomavirus-11- associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease. Pediatr Develop Pathol 4 :68-72.
35. Rimell FL, Shoemaker DL, Pou AM, et al (1997) Pediatric respiratory papillomatosis: prognostic role of viral typing and cofactors. Laryngoscope 107:915-918.
36. Rosen CA, Woodson GE, Thompson JW, et al (1998) Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis. Otolaryngol Head Neck Surg 118:810-815.
37. Schraff S, Derkay CS, Burke B, et al (2004) American Society of Pediatric Otolaryngology members' experience with recurrent respiratory papillomatosis and the use of adjuvant therapy. Arch Otolaryngol Head Neck Surg 130:1039-1042.
38. Shah K, Kashima H, Polk BF, et al (1986) Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol 68:795-799.
39. Shah KV, Stern WF, Shah FK, et al (1998) Risk factors for juvenile onset recurrent respiratory papillomatosis. Pediatr Infect Dis J 17:372-376.
40. Shapiro AM, Rimell FL, Shoemaker D, et al (1996) Tracheotomy in children with juvenile-onset recurrent respiratory papillomatosis: The Children's Hospital of Pittsburgh experience. Ann Otol Rhinol Laryngol 105:1-5.
41. Shikowitz MJ, Abramson AL, Steinberg BM, et al (2005) Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 131:99-105.
42. Shirley WP, Wiatrak B (2004) Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children? Int J Pediatr Otorhinolaryngol 68:413-418.
43. Snoeck R, Wellens W, Desloovere C, et al (1998) Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethox ypropyl)cytosine]. J Med Virol 54:219-225.
44. Solomon D, Smith RR, Kashima HK, et al (1985) Malignant transformation in non-irradiated recurrent respiratory papillomatosis. Laryngoscope 95:900-904.
45. Steinberg BM, Gallagher T, Stoler M, et al (1988) Persistence and expression of human papillomavirus during interferon therapy. Arch Otolaryngol Head Neck Surg 114:27-32.
46. Tenti P (1999) Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol 93:475-479.
47. Ullmann EV (1923) On the etiology of laryngeal papilloma. Acta Otolaryngol 5:317-374.
48. Vambutas A, Bonagura VR, Steinberg BM (2000) Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease. Clin Diagn Lab Immunol 7:79-85.
49. Van Valckenborgh I, Wellens W, De Boeck K, et al (2001) Systemic cidofovir in papillomatosis. Clin Infect Dis 32: E62-E64.
50. Wiatrak BJ, Wiatrak DW, Broker TR, et al (2004) Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. Laryngoscope 114:1-23.